3579

    506690

    UNICHEMLAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    UNICHEM LABORATORIES LTD Share Price Today

    UNICHEM LABORATORIES LTD is currently trading at ₹589.05, down by ₹15.79 from the previous close. The stock touched an intraday high of ₹603.20 and a low of ₹571.95 during the latest trading session. Over the past one year, UNICHEM LABORATORIES LTD has delivered a loss of 6.63%, while the stock has gained 31.06% in the last one month.

    UNICHEM LABORATORIES LTD performance

    Today’s low Today’s high
    ₹ 571.95 ₹ 603.20
    ₹ 589.05
    52 week low 52 week high
    ₹ 278.20 ₹ 687.20
    ₹ 589.05
    Open Price ₹ 598.10
    Prev. Close ₹ 604.85
    Volume (Shares) 158364.00
    Total traded value ₹ 932.84
    Upper Circuit ₹ 665.30
    Lower Circuit ₹ 544.40
    info

    Investment Returns

    Over 1 Month 31.06% Over 3 Months 67.72% Over 6 Months 48.28% Over 1 Year -6.63%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    UNICHEM LABORATORIES LTD fundamentals


    • Market cap (Cr) 4,147.30
    • P/E Ratio (TTM) 26.14
    • Beta 0.66
    • Book Value / share 373.13
    • Return on equity -0.61%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -15.39
    info icon alternate text
    • Market cap (Cr) 4,153.60
    • P/E Ratio (TTM) 26.14
    • Beta 0.57
    • Book Value / share 373.13
    • Return on equity -0.61%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -15.39
    info icon alternate text

    UNICHEM LABORATORIES LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 356.24
    Operating Expense 376.81
    Net Profit -15.39
    Net Profit Margin (%) -4.32
    Earnings Per Share (EPS) -2.19
    EBITDA 22.34
    Effective Tax Rate (%) -43.69
    Particulars DEC 2025 (Values in Cr)
    Revenue 314.90
    Operating Expense 345.63
    Net Profit 216.11
    Net Profit Margin (%) 68.62
    Earnings Per Share (EPS) 30.69
    EBITDA 291.94
    Effective Tax Rate (%) 16.82
    Particulars SEP 2025 (Values in Cr)
    Revenue 356.90
    Operating Expense 382.99
    Net Profit -39.93
    Net Profit Margin (%) -11.18
    Earnings Per Share (EPS) -5.67
    EBITDA -4.03
    Effective Tax Rate (%) -5.55
    Particulars JUN 2025 (Values in Cr)
    Revenue 384.25
    Operating Expense 390.37
    Net Profit -1.85
    Net Profit Margin (%) -0.48
    Earnings Per Share (EPS) -0.26
    EBITDA 29.99
    Effective Tax Rate (%) 1.06
    Particulars MAR 2025 (Values in Cr)
    Revenue 461.24
    Operating Expense 415.26
    Net Profit 51.22
    Net Profit Margin (%) 11.10
    Earnings Per Share (EPS) 7.28
    EBITDA 85.03
    Effective Tax Rate (%) 8.58
    Particulars MAR 2026 (Values in Cr)
    Revenue 1412.29
    Operating Expense 1492.76
    Net Profit 158.94
    Net Profit Margin (%) 11.25
    Earnings Per Share (EPS) 22.57
    EBITDA 340.24
    Effective Tax Rate (%) 24.10
    Particulars MAR 2025 (Values in Cr)
    Revenue 1735.70
    Operating Expense 1597.85
    Net Profit 162.96
    Net Profit Margin (%) 9.38
    Earnings Per Share (EPS) 23.15
    EBITDA 298.71
    Effective Tax Rate (%) 10.79
    Particulars MAR 2024 (Values in Cr)
    Revenue 1442.16
    Operating Expense 1507.12
    Net Profit -92.18
    Net Profit Margin (%) -6.39
    Earnings Per Share (EPS) -13.09
    EBITDA 23.68
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 1072.43
    Operating Expense 1280.70
    Net Profit -299.70
    Net Profit Margin (%) -27.94
    Earnings Per Share (EPS) -42.57
    EBITDA -163.72
    Effective Tax Rate (%) -7.38
    Particulars MAR 2022 (Values in Cr)
    Revenue 942.93
    Operating Expense 1071.74
    Net Profit -55.43
    Net Profit Margin (%) -5.87
    Earnings Per Share (EPS) -7.87
    EBITDA -1.49
    Effective Tax Rate (%) 36.10
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 386.00
    ROE % 3.17
    ROCE % 4.09
    Total Debt to Total Equity 0.19
    EBITDA Margin 11.43
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 348.10
    ROE % 5.63
    ROCE % 6.19
    Total Debt to Total Equity 0.14
    EBITDA Margin 14.22
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 346.35
    ROE % -1.79
    ROCE % -0.23
    Total Debt to Total Equity 0.12
    EBITDA Margin 6.55
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 345.89
    ROE % -7.05
    ROCE % -4.51
    Total Debt to Total Equity 0.13
    EBITDA Margin -1.29
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 371.90
    ROE % 1.22
    ROCE % 0.88
    Total Debt to Total Equity 0.09
    EBITDA Margin 9.16
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 373.17
    ROE % -0.61
    ROCE % -0.12
    Total Debt to Total Equity 0.04
    EBITDA Margin 8.19
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 349.40
    ROE % 6.86
    ROCE % 7.58
    Total Debt to Total Equity 0.04
    EBITDA Margin 17.21
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 325.94
    ROE % -1.55
    ROCE % -1.05
    Total Debt to Total Equity 0.04
    EBITDA Margin 5.52
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 338.65
    ROE % -7.77
    ROCE % -5.88
    Total Debt to Total Equity 0.05
    EBITDA Margin -4.88
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 379.52
    ROE % -2.06
    ROCE % -3.03
    Total Debt to Total Equity 0.02
    EBITDA Margin -0.16
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 294.70
    Total Assets 3737.44
    Total Liabilities 3737.44
    Total Equity 2717.44
    Share Outstanding 7
    Price to Book Ratio 0.79
    Return on Assets (%) 6.76
    Return on Capital (%) 7.94
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 117.63
    Total Assets 3569.40
    Total Liabilities 3569.40
    Total Equity 2450.59
    Share Outstanding 7
    Price to Book Ratio 1.98
    Return on Assets (%) 3.85
    Return on Capital (%) 4.77
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 158.16
    Total Assets 3274.95
    Total Liabilities 3274.95
    Total Equity 2438.30
    Share Outstanding 7
    Price to Book Ratio 1.50
    Return on Assets (%) -2.86
    Return on Capital (%) -3.53
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 185.36
    Total Assets 3193.04
    Total Liabilities 3193.04
    Total Equity 2435.30
    Share Outstanding 7
    Price to Book Ratio 0.85
    Return on Assets (%) -6.33
    Return on Capital (%) -7.4
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 114.10
    Total Assets 3318.77
    Total Liabilities 3318.77
    Total Equity 2618.41
    Share Outstanding 7
    Price to Book Ratio 0.69
    Return on Assets (%) 0.99
    Return on Capital (%) 1.12
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 257.89
    Total Assets 3092.45
    Total Liabilities 3092.45
    Total Equity 2627.10
    Share Outstanding 7
    Price to Book Ratio 0.79
    Return on Assets (%) 5.13
    Return on Capital (%) 5.93
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 88.63
    Total Assets 3109.21
    Total Liabilities 3109.21
    Total Equity 2459.75
    Share Outstanding 7
    Price to Book Ratio 1.98
    Return on Assets (%) 5.24
    Return on Capital (%) 6.34
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 129.06
    Total Assets 2841.51
    Total Liabilities 2841.51
    Total Equity 2294.63
    Share Outstanding 7
    Price to Book Ratio 1.50
    Return on Assets (%) -3.24
    Return on Capital (%) -3.91
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 157.27
    Total Assets 2886.13
    Total Liabilities 2886.13
    Total Equity 2384.27
    Share Outstanding 7
    Price to Book Ratio 0.85
    Return on Assets (%) -10.38
    Return on Capital (%) -12.06
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 99.03
    Total Assets 3122.08
    Total Liabilities 3122.08
    Total Equity 2672.04
    Share Outstanding 7
    Price to Book Ratio 0.69
    Return on Assets (%) -1.77
    Return on Capital (%) -1.98
    Particulars MAR 2026 (Values in Cr)
    Net Income 292.38
    Cash from Operations 11.21
    Cash from Investing 192.06
    Cash from Financing 1.86
    Net change in Cash 197.56
    Free Cash Flow 134.25
    Particulars MAR 2025 (Values in Cr)
    Net Income 154.59
    Cash from Operations 9.40
    Cash from Investing -241.23
    Cash from Financing 183.76
    Net change in Cash -64.49
    Free Cash Flow 146.76
    Particulars MAR 2024 (Values in Cr)
    Net Income -84.96
    Cash from Operations 20.37
    Cash from Investing 50.40
    Cash from Financing -106.31
    Net change in Cash -41.91
    Free Cash Flow 42.92
    Particulars MAR 2023 (Values in Cr)
    Net Income -176.36
    Cash from Operations -72.88
    Cash from Investing 202.81
    Cash from Financing -81.29
    Net change in Cash 36.42
    Free Cash Flow -28.56
    Particulars MAR 2022 (Values in Cr)
    Net Income 21.96
    Cash from Operations -251.99
    Cash from Investing 102.39
    Cash from Financing 191.22
    Net change in Cash 34.01
    Free Cash Flow -124.99
    Particulars MAR 2026 (Values in Cr)
    Net Income 209.41
    Cash from Operations 52.26
    Cash from Investing 207.81
    Cash from Financing -70.66
    Net change in Cash 189.75
    Free Cash Flow 170.85
    Particulars MAR 2025 (Values in Cr)
    Net Income 182.68
    Cash from Operations 72.57
    Cash from Investing -174.94
    Cash from Financing 38.26
    Net change in Cash -64.39
    Free Cash Flow 185.38
    Particulars MAR 2024 (Values in Cr)
    Net Income -92.18
    Cash from Operations -41.42
    Cash from Investing 53.24
    Cash from Financing -48.06
    Net change in Cash -36.39
    Free Cash Flow -21.05
    Particulars MAR 2023 (Values in Cr)
    Net Income -279.08
    Cash from Operations -117.23
    Cash from Investing 202.49
    Cash from Financing -61.75
    Net change in Cash 23.40
    Free Cash Flow -75.18
    Particulars MAR 2022 (Values in Cr)
    Net Income -86.74
    Cash from Operations -162.36
    Cash from Investing 106.31
    Cash from Financing 95.80
    Net change in Cash 43.80
    Free Cash Flow -35.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD. 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LTD. 431.50 19.03 3.12 1269.95 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD. 482.50 52.16 4.42 5117.21 118.35 552.90

    UNICHEM LABORATORIES LTD shareholding pattern

    Holding
    18.41%
    70.22%
    0.9%
    10.45%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    UNICHEM LABORATORIES LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    589.05 -2.61 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 592.00
    • 26 Days 511.80
    • 10 Days 572.10
    • 50 Days 463.60
    • 12 Days 562.90
    • 100 Days 429.70
    • 20 Days 530.60
    • 200 Days 440.10
    605.45 PIVOT
    First Support 586.60 First Resistance 623.70 Second Support 568.35 Second Resistance 642.55 Third Support 549.50 Third Resistance 660.80
    RSI 65.89 ADX 64.38 MACD 51.09 Williams % R -41.01 Commodity Channel Index (CCI) 69.81
    Date 2026-07-17 Week 80840.00 Same Day 49663.00 Month 135012.00
    1 Year 0.67 3 Year 0.66
    Over 1 Month
    31.06% down
    Over 1 Year
    -6.63% down
    Over 3 Months
    67.72% down
    Over 3 Years
    15.37% down
    Over 6 Months
    48.28% down
    Over 5 Years
    11.63% down

    UNICHEM LABORATORIES LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    01 Aug 2022 4.0 Final 03 Aug 2022 Equity shares
    22 Jul 2021 4.0 Final 26 Jul 2021 Equity shares
    20 Aug 2020 4.0 Final 24 Aug 2020 Equity shares
    18 Jul 2019 4.0 Final 22 Jul 2019 Equity shares
    19 Jul 2018 5.0 Final 23 Jul 2018 Equity shares
    13 Jul 2017 3.0 Final 17 Jul 2017 Equity shares
    17 Mar 2016 2.0 Interim 19 Mar 2016 Equity shares
    02 Jul 2015 2.0 Final 06 Jul 2015 Equity shares
    03 Jul 2014 4.0 Final 07 Jul 2014 Equity shares
    23 Jan 2014 4.0 Interim 24 Jan 2014 Equity shares
    11 Jul 2013 4.5 Final 15 Jul 2013 Equity shares
    13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
    14 Jul 2011 2.8 Final 18 Jul 2011 Equity shares
    21 Oct 2010 3.0 Interim 22 Oct 2010 Equity shares
    14 May 2010 7.0 Interim 2 17 May 2010 Equity shares
    27 Oct 2009 3.0 Interim 28 Oct 2009 Equity shares
    09 Jul 2009 5.0 Final 13 Jul 2009 Equity shares
    29 Oct 2008 3.0 Interim 31 Oct 2008 Equity shares
    10 Jul 2008 5.0 Final 14 Jul 2008 Equity shares
    16 Mar 2007 5.0 Final 20 Mar 2007 Equity shares
    13 Jul 2006 0.0 Final 16 Jul 2006 Equity shares
    14 Jul 2005 0.0 Final 18 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    24 Mar 2004 16 Mar 2004 1:1
    20 Apr 2000 04 Apr 2000 1:1
    20 Apr 2000 03 Apr 2000 1:1
    Ex-Date Old FV NEW FV Record Date
    21 Oct 2010 5.0 2.0 22 Oct 2010
    16 Mar 2004 10.0 5.0 24 Mar 2004
    16 Mar 2004 10.0 5.0 24 Mar 2004
    Dividend date Dividend amount Dividend type Record date Instrument type
    01 Aug 2022 4.0 Final 03 Aug 2022 Equity shares
    22 Jul 2021 4.0 Final 26 Jul 2021 Equity shares
    20 Aug 2020 4.0 Final 24 Aug 2020 Equity shares
    18 Jul 2019 4.0 Final 22 Jul 2019 Equity shares
    19 Jul 2018 5.0 Final 23 Jul 2018 Equity shares
    13 Jul 2017 3.0 Final 17 Jul 2017 Equity shares
    17 Mar 2016 2.0 Interim 19 Mar 2016 Equity shares
    02 Jul 2015 2.0 Final 06 Jul 2015 Equity shares
    03 Jul 2014 4.0 Final 07 Jul 2014 Equity shares
    23 Jan 2014 4.0 Interim 24 Jan 2014 Equity shares
    11 Jul 2013 4.5 Final 15 Jul 2013 Equity shares
    13 Sep 2012 3.0 Final 17 Sep 2012 Equity shares
    14 Jul 2011 2.8 Final 18 Jul 2011 Equity shares
    21 Oct 2010 3.0 Interim 22 Oct 2010 Equity shares
    14 May 2010 7.0 Interim 2 17 May 2010 Equity shares
    27 Oct 2009 3.0 Interim 28 Oct 2009 Equity shares
    09 Jul 2009 5.0 Final 13 Jul 2009 Equity shares
    29 Oct 2008 3.0 Interim 31 Oct 2008 Equity shares
    10 Jul 2008 5.0 Final 14 Jul 2008 Equity shares
    16 Mar 2007 5.0 Final 20 Mar 2007 Equity shares
    13 Jul 2006 0.0 Final 16 Jul 2006 Equity shares
    14 Jul 2005 0.0 Final 18 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    24 Mar 2004 16 Mar 2004 1:1
    20 Apr 2000 04 Apr 2000 1:1
    20 Apr 2000 03 Apr 2000 1:1
    Ex-Date Old FV NEW FV Record Date
    21 Oct 2010 5.0 2.0 22 Oct 2010
    16 Mar 2004 10.0 5.0 24 Mar 2004
    16 Mar 2004 10.0 5.0 24 Mar 2004

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Unichem Laboratories Ltd?

    Answer Field

    Unichem Laboratories Ltd share price is for NSE ₹ 589.05 & for BSE ₹ 585.95 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Unichem Laboratories Ltd Share?

    Answer Field

    The market cap of Unichem Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Unichem Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Unichem Laboratories Ltd for NSE is ₹ 687.20 and ₹ 278.20 and for BSE is ₹ 685.95 and ₹ 280.00.

    What is 1 year return for Unichem Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -6.63%.

    What is the P/E Ratio of Unichem Laboratories Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Unichem Laboratories Ltd share is 26.14.

    What is the PB ratio of Unichem Laboratories Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Unichem Laboratories Ltd share is 373.13.

    How to Buy Unichem Laboratories Ltd Share?

    Answer Field

    You can trade in Unichem Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Unichem Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Unichem Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Unichem Laboratories Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |